EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Aeolus Pharmaceuticals Inc. (AOLS) had EBIT Margin of -157.66% for the most recently reported fiscal year, ending 2016-09-30.
| Income Statement Financials | |
$2.08M |
|
$-6.04M |
|
-- |
|
$2.08M |
|
$5.35M |
|
$-3.27M |
|
$-0.28M |
|
$-3.56M |
|
$-3.56M |
|
$-3.56M |
|
$-3.56M |
|
$-3.56M |
|
$-3.56M |
|
$-3.27M |
|
$-2.99M |
|
148.67M |
|
148.67M |
|
$-0.04 |
|
$-0.04 |
|
| Balance Sheet Financials | |
$4.13M |
|
-- |
|
$0.03M |
|
$4.17M |
|
$0.97M |
|
-- |
|
-- |
|
$0.97M |
|
$3.19M |
|
$3.19M |
|
$3.19M |
|
152.09M |
|
| Cash Flow Statement Financials | |
$-3.11M |
|
-- |
|
$6.17M |
|
$0.09M |
|
$3.15M |
|
$3.06M |
|
$0.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.25 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-157.66% |
|
|
EBIT Margin |
-157.66% |
-143.93% |
|
-171.39% |
|
-291.14% |
|
$-3.11M |
|
-- |
|
-- |
|
-- |
|
0.50 |
|
-- |
|
2.77 |
|
131.86 |
|
-111.36% |
|
-111.36% |
|
-85.39% |
|
-111.36% |
|
$0.02 |
|
$-0.02 |
|
$-0.02 |
|